GlassScriptPhysician profile
Daniel C Touma
NPI 1205214152
$1,022.09
in general payments reported to CMS, 2019-2025
17 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.36 · 2020: $119 · 2021: $199 · 2022: $194 · 2023: $226 · 2024: $102 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $221.72 | 2019-2023 | Xarelto |
| Pfizer INC. | $150.85 | 2019-2025 | |
| Abbvie INC. | $129.13 | 2022-2025 | Teflaro |
| Allergan, INC. | $100.00 | 2020 | |
| Inari Medical, INC. | $79.04 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $77.98 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $64.15 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.07 | 2025 | Xifaxan |
| Shionogi INC | $22.06 | 2022 | |
| Atricure, INC. | $22.00 | 2024 | |
| Abiomed | $21.86 | 2025 | |
| Medtronic, INC. | $21.54 | 2025 | Intellis Adaptivestim |
| Abbott Laboratories | $19.57 | 2023 | Mitraclip |
| Smith+Nephew, INC. | $18.37 | 2025 | Collagenase Santyl |
| Stryker Corporation | $18.30 | 2025 | Flowtriever |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $16.82 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Touma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.